Search clinical trials for: Levalbuterol

Total 33 results

Sunovion

Completed

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

Asthma

United States
Duke University

Completed

Aerosolized Beta-Agonist Isomers in Asthma

Asthma
Sunovion

Completed

A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma

Asthma
Sunovion

Terminated

A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects

Asthma

United States
Sunovion

Completed

A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma

Asthma

United States
Sunovion

Completed

A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma

Asthma

United States
Sunovion

Completed

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

Asthma

United States
Sunovion

Completed

Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma

Asthma

United States
Children's Hospital Los Angeles

Completed

Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults

Oxygen Consumption
Phoenix Children's Hospital

Completed

Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED) (Xopenex)

Asthma

United States
Sunovion

Completed

Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol

Asthma | Bronchoconstriction

United States
Sunovion

Completed

Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB

Exercise-induced Bronchospasm

United States
Sunovion

Completed

Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects

Asthma | Bronchoconstriction

United States
University of Aleppo

Recruiting

Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.

Hyperkalemia

Syrian Arab Republic
Children's Hospital of Philadelphia
Sunovion

Completed

Continuous Levalbuterol for Treatment of Status Asthmaticus in Children

Asthma

United States
Sunovion

Completed

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

Asthma

United States
Sunovion

Completed

A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects

Asthma

United States
Sunovion

Completed

Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma

Asthma

United States
Sunovion

Completed

Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma

Asthma

United States, Canada
Sanofi
Regeneron Pharmaceuticals

Completed

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)

Asthma

Spain, Canada, United States, Korea, Republic of, Mexico, Brazil, Germany, Taiwan, Argentina, Australia, Colombia, France, Hungary, Japan, Poland, Russian Federation, South Africa, Turkey, Ukraine, United Kingdom, Italy, Chile
Sunovion

Completed

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Chronic Obstructive Pulmonary Disease | Asthma | COPD

United States
Sunovion

Completed

Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects (POLARIS)

Asthma | COPD

United States
Henry Ford Health System
Sunovion

Terminated

A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients

Acute Asthma

United States
Fahim Khorfan, MD
Ascension Genesys Hospital

Completed

Effect of Nebulized Bronchodilators on Heart Rate

Sepsis | Shock | COPD

United States
Sunovion

Completed

Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Canada
NCIC Clinical Trials Group
National Cancer Institute (NCI); Southwest Oncology Group

Completed

Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

Prostate Cancer

Canada
Sunovion

Completed

Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma

Asthma

United States
Johns Hopkins University
Sunovion

Completed

Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol

Mucociliary Clearance

United States
Sunovion

Completed

Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD)

Reactive Airways Disease (RAD)

United States, Canada
Sanofi
Regeneron Pharmaceuticals

Completed

An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma

Asthma

Spain, United States, Chile, Australia, France, Mexico, Argentina, Italy, Japan, Poland, Russian Federation, South Africa, Turkey, Ukraine, Korea, Republic of, New Zealand
University of Illinois at Chicago
National Heart, Lung, and Blood Institute (NHLBI)

Completed

COPD Assessment and Management Bundle Versus Usual Care

Chronic Obstructive Pulmonary Disease

United States
Sanofi
Regeneron Pharmaceuticals

Completed

Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma (VENTURE)

Asthma

Belgium, Israel, United States, Mexico, Argentina, Brazil, Canada, Chile, Colombia, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, Ukraine
Sanofi
Regeneron Pharmaceuticals

Completed

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

Asthma

United States

3

Subscribe